logo

For the Inventor, By the Inventor

Folkestone, United Kingdom

Richard Storer

This inventor holds 18 USPTO granted patents and 16 published patent applications and 12 EPO patents, primarily in Antiviral Compounds. Top assignees: Idenix Pharmaceuticals, Inc., Summit Corporation Plc, Centre National De La Recherche Scientifique. Active years: 2008-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Richard Storer. Retrieved from https://idiyas.com/inventor/richard-storer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 18 

% Patents Active = 72.2

 

Average Co-Inventor Count = 4.1

ph-index = 5

Forward Citations = 145(Granted Patents)


Location History:

  • Kent, GB (2009 - 2014)
  • Folkestone, GB (2008 - 2015)
  • Oxfordshire, GB (2015)
  • Abingdon, GB (2016 - 2017)

Company Filing History:

goldMedal10 out of 100 
 
Idenix Pharmaceuticals, Inc.
 patents
silverMedal3 out of 6 
 
Summit Corporation Plc
 patents
bronzeMedal2 out of 5,383 
 
Centre National De La Recherche Scientifique
 patents
4. 2 out of 3,978 
 
Novartis Ag
 patents
5. 2 out of 3 
 
Summit Therapeutics Plc
 patents
6. 1 out of 1 
 
L'universite Montpelier Ii
 patent
7. 1 out of 13 
 
L'université Montpellier Ii
 patents
8. 1 out of 37 
 
Novartis Pharma Ag
 patents
9. 1 out of 4 
 
University of Cagliari
 patents
where one patent can have more than one assignee

Years Active: 2008-2017

Loading Chart...
Loading Chart...
Areas of Expertise:
Antibacterial Compounds
Nucleoside Analogues
HIV Inhibitors
Duchenne Muscular Dystrophy
Phospho-Indoles
Drug Combinations
Nucleoside Synthesis
Beta-L-2'-Deoxythymidine
18 patents (USPTO):Explore Patents
1. 9763925 - Antibacterial compounds (2017-09-19),
2. 9314456 - Antibacterial compounds (2016-04-19),
3. 9186369 - Purine nucleoside analogues for treating flaviviridae including hepatitis C (2015-11-17),
4. 8975416 - Antibacterial compounds (2015-03-10),
5. 8742101 - [object Object] (2014-06-03),
6. 8637475 - Modified 2' and 3′ nucleoside prodrugs for treating flaviviridae infections (2014-01-28),
7. 8518980 - Treatment of Duchenne muscular dystrophy (2013-08-27),
8. 8501713 - Drug combinations for the treatment of duchenne muscular dystrophy (2013-08-06),
9. 8486991 - Enantiomerically pure phosphoindoles as HIV inhibitors (2013-07-16),
10. 8044091 - Phospho-indoles as HIV inhibitors (2011-10-25),
11. 7960428 - Enantiomerically pure phosphoindoles as HIV inhibitors (2011-06-14),
12. 7858594 - Crystalline and amorphous forms of beta-L-2'-deoxythymidine (2010-12-28),
13. 7598373 - Process for the production of 2-C-methyl-D-ribonolactone (2009-10-06),
14. 7595390 - Industrially scalable nucleoside synthesis (2009-09-29),
15. 7589079 - Crystalline and amorphous forms of beta-L-2'-deoxythymidine (2009-09-15),

Title: Richard Storer - Innovative Inventor from Folkestone

Introduction: Richard Storer is a renowned inventor hailing from Folkestone, Great Britain. With a passion for creating groundbreaking solutions, he has made significant contributions to the field of innovation.

Latest Patents: Richard Storer holds several patents in various industries, including technology, healthcare, and sustainability. His recent patents focus on enhancing user experience through cutting-edge design and functionality.

Career Highlights: Throughout his career, Richard Storer has been recognized for his inventive spirit and problem-solving skills. He has received numerous awards for his innovative creations, showcasing his dedication to pushing the boundaries of technology.

Collaborations: Richard Storer has collaborated with leading companies and research institutions to bring his ideas to life. His partnerships have resulted in the development of revolutionary products that have had a lasting impact on the market.

Conclusion: Richard Storer's relentless pursuit of innovation and his ability to think outside the box have solidified his reputation as a visionary inventor in Folkestone and beyond. His work continues to inspire the next generation of inventors to dream big and create the impossible.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…